PAD Clinical Presentations

1
PADClinical Presentations
2
Individuals With PAD Present in Clinical Practice
With Distinct Syndromes
This guideline recognizes that

• Asymptomatic Without obvious symptomatic
  complaint (but usually with a functional
  impairment).
• Classic claudication Lower extremity symptoms
  confined to the muscles with a consistent
  (reproducible) onset with exercise and relief
  with rest.
• Atypical leg pain Lower extremity discomfort
  that is exertional but that does not consistently
  resolve with rest, consistently limit exercise at
  a reproducible distance, or meet all Rose
  questionnaire criteria.

3
Individuals With PAD Present in Clinical Practice
With Distinct Syndromes
This guideline recognizes that

• Critical limb lschemia Ischemic rest pain,
  nonhealing wound, or gangrene/
• Acute limb ischemia The five Ps, defined by
  the clinical symptoms and signs that suggest
  potential limb jeopardy
• Pain
• Pulselessness
• Pallor
• Paresthesias
• Paralysis ( polar, as a sixth P).

4
Clinical Presentations of PAD
15
Classic (Typical) Claudication
50 Asymptomatic
33
Atypical Leg Pain(functionally limited)
5
Claudication vs. Pseudoclaudication
Also see Table 4 of Hirsch AT, et al. J Am Coll
Cardiol. 200647e1-e192.
6
Leg Pain Has a Differential Diagnosis

• Spinal canal stenosis
• Peripheral neuropathy
• Peripheral nerve pain
• Herniated disc impinging on sciatic nerve
• Osteoarthritis of the hip or knee
• Venous claudication
• Symptomatic Bakers cyst
• Chronic compartment syndrome
• Muscle spasms or cramps
• Restless leg syndrome

Also see Table 3 of Hirsch AT, et al. J Am Coll
Cardiol. 200647e1-e192.
7
ABI and Functional Outcomes
Proportion Stopping During 6-Minute Walk
Mean Distance Achieved in 6-Minute Walk
70
60
50
1600
40
1200
Patients ()
30
800
Feet
20
400
10
0
0
1.2-1.5
lt0.4
0.4-0.5
0.5-0.6
0.6-0.7
0.7-0.8
0.8-0.9
0.9-1.0
1.0-1.1
1.1-1.2
lt0.5
0.5-0.7
0.7-0.9
0.9-1.1
1.1-1.5
ABI
ABI
ABIankle-brachial index
McDermott MM, et al. Ann Intern Med.
2002136873-883.
8
Factors That Increase Risk of Limb Loss in
Patients With Critical Limb Ischemia

• Factors that reduce blood flow to the
  microvascular bed
• Diabetes
• Severe renal failure
• Severely decreased cardiac output (severe heart
  failure or shock)
• Vasospastic diseases or concomitant conditions
  (e.g., Raynauds phenomenon, prolonged cold
  exposure)
• Smoking and tobacco use
• Factors that increase demand for blood flow to
  the microvascular bed
• Infection (e.g., cellulitis, osteomyelitis)
• Skin breakdown or traumatic injury

Also see Table 5 of Hirsch AT, et al. J Am Coll
Cardiol. 200647e1-e192.
9
Objectives for Diagnostic Evaluation of Patients
With Critical Limb Ischemia

• Localization of the responsible lesion(s) and
  measurement of relative severity
• Assessment of the hemodynamic requirements for
  successful revascularization (vis-à-vis proximal
  versus combined revascularization of multilevel
  disease)
• Assessment of individual patient endovascular or
  operative risk

Also see Table 6 of Hirsch AT, et al. J Am Coll
Cardiol. 200647e1-e192.
10
Differential Diagnosis of Common Foot Ulcers
Reprinted with permission from Dormandy JA,
Rutherford RB. J Vasc Surg. 200031S1-S296.
11
Etiologic Classification of Foot and Leg Ulcers

• Venous obstruction and insufficiency
• Arterial etiologies
• Larger arteries
• Atherosclerotic lower extremity PAD
• Thromboemboli, atheroemboli
• Thromboangiitis obliterans
• Microcirculatory
• Diabetic microangiopathy
• Vasculitis
• Collagen vascular diseases
• Neuropathic
• Diabetes mellitus

• Infectious
• Leprosy
• Mycotic
• Hematologic
• Sickle cell anemia
• Polycythemia
• Thrombocytosis
• Malignancy
• Squamous cell carcinoma
• Kaposis sarcoma
• Artifactual or factitious

Also see Table 10 of Hirsch AT, et al. J Am Coll
Cardiol. 200647e1-e192.
12
The Vascular History and Physical Examination

• Individuals at risk for lower extremity PAD
• should undergo a vascular review of
• symptoms to assess walking impairment,
• claudication, ischemic rest pain, and/or the
• presence of nonhealing wounds.
• Individuals at risk for lower extremity PAD
• should undergo comprehensive pulse
• examination and inspection of the feet.

13
Identification of the Asymptomatic Patient With
PAD

• A history of walking impairment, claudication,
• and ischemic rest pain is recommended as a
• required component of a standard review of
• systems for adults gt50 years who have
• atherosclerosis risk factors, or for adults gt70
  years.
• Individuals with asymptomatic PAD should be
• identified in order to offer therapeutic
• interventions known to diminish their
• increased risk of myocardial infarction, stroke,
• and death.

14
Identification of the Symptomatic Patient With
Intermittent Claudication

• Patients with symptoms of intermittent
• claudication should undergo a vascular
• physical examination, including measurement
• of the ABI.
• In patients with symptoms of intermittent
• claudication, the ABI should be measured after
• exercise if the resting index is normal.

15
Identification of the Symptomatic Patient With
Intermittent Claudication

• Patients with intermittent claudication should
• have significant functional impairment with a
• reasonable likelihood of symptomatic
• improvement and absence of other disease that
• would comparably limit exercise even if the
• claudication was improved (e.g., angina, heart
• failure, chronic respiratory disease, or
• orthopedic limitations) before undergoing an
• evaluation for revascularization.

16
Revascularization of the Patient With
Intermittent Claudication

• Individuals with intermittent claudication who
  are offered the option of endovascular or
  surgical therapies should
• be provided information regarding supervised
  claudication exercise therapy and
  pharmacotherapy
• receive comprehensive risk factor modification
  and antiplatelet therapy
• have a significant disability, either being
  unable to perform normal work or having serious
  impairment of other activities important to the
  patient
• have lower extremity PAD lesion anatomy such that
  the revascularization procedure would have low
  risk and a high probability of initial and
  long-term success.

17
Evaluation of the Patient With Critical Limb
Ischemia

• Patients with CLI should undergo expedited
• evaluation and treatment of factors that are
• known to increase the risk of amputation.
• Patients with CLI in whom open surgical repair is
  
• anticipated should undergo assessment of
• cardiovascular risk.

18
Evaluation of the Patient With Critical Limb
Ischemia

• Patients at risk of CLI (ABI less than 0.4 in a
• nondiabetic individual, or any diabetic
• individual with known lower extremity PAD)
• should undergo regular inspection of the feet
• to detect objective signs of CLI.
• The feet should be examined directly, with
• shoes and socks removed, at regular intervals
• after successful treatment of CLI.

19
Evaluation of the Patient With Critical Limb
Ischemia

• Patients with CLI and skin breakdown should
• be referred to healthcare providers with
• specialized expertise in wound care.
• Patients at risk for CLI (those with diabetes,
• neuropathy, chronic renal failure, or infection)
• who develop acute limb symptoms represent
• potential vascular emergencies and should be
• assessed immediately and treated by a
• specialist competent in treating vascular
• disease.

20
Surveillance of the Patient With Prior
Infra-inguinal Bypass Graft

• Long-term patency of infrainguinal bypass
• grafts should be evaluated in a surveillance
• program, which should include an interval
• vascular history, resting ABIs, physical
• examination, and a Duplex ultrasound at
• regular intervals if a venous conduit has been
• used.

21
The Clinical Approach to the Patient With, or at
Risk for, PAD
Clinicians who care for individuals with PAD
should be able to provide

• A vascular review of symptoms
• A vascular-focused physical examination
• Use of the noninvasive vascular diagnostic
  laboratory (ABI and toe-brachial index TBI,
  exercise ABI, Duplex ultrasound, magnetic
  resonance angiography MRA, and computed
  tomographic angiography CTA)
• When required, use of diagnostic catheter-based
  angiography

22
The Vascular Review of Symptoms An Essential
Component of the Vascular History

• Key components of the vascular review of systems
  (not usually included in the review of systems of
  the extremities) and family history include the
  following
• Any exertional limitation of the lower extremity
  muscles or any history of walking impairment. The
  characteristics of this limitation may be
  described as fatigue, aching, numbness, or pain.
  The primary site(s) of discomfort in the buttock,
  thigh, calf, or foot should be recorded, along
  with the relation of such discomfort to rest or
  exertion.
• Any poorly healing or nonhealing wounds of the
  legs or feet.
• Any pain at rest localized to the lower leg or
  foot and its association with the upright or
  recumbent positions.
• Post-prandial abdominal pain that reproducibly is
  provoked by eating and is associated with weight
  loss.
• Family history of a first-degree relative with an
  abdominal aortic aneurysm.

23
Comprehensive Vascular Examination
Key components of the vascular physical
examination include

• Pulse Examination
• Carotid
• Radial/ulnar
• Femoral
• Popliteal
• Dorsalis pedis
• Posterior tibial
• Scale
• 0Absent
• 1Diminished
• 2Normal
• 3Bounding (aneurysm or AI)

• Bilateral arm blood pressure (BP)
• Cardiac examination
• Palpation of the abdomen for aneurysmal disease
• Auscultation for bruits
• Examination of legs and feet

24
The First Tool to Establish the PAD DiagnosisA
Standardized Physical Examination

• Pulse intensity should be assessed and should be
  recorded numerically as follows
• 0, absent
• 1, diminished
• 2, normal
• 3, bounding

Use of a standard examination should facilitate
clinical communication
25
Differential Diagnosis of PAD

• Atherosclerosis
• Vasculitis
• Fibromuscular dysplasia
• Atheroembolic disease
• Thrombotic disorders
• Trauma
• Radiation
• Popliteal aneurysm
• Thromboangiitis obliterans (Buergers disease)

• Popliteal entrapment
• Cystic adventitial disease
• Coarctation of aorta
• Vascular tumor
• Iliac syndrome of the cyclist
• Pseudoxanthoma elasticum
• Persistent sciatic artery (thrombosed)

26
ACC/AHA Guideline for the Management of
PADSteps Toward the Diagnosis of PAD
Recognizing the at risk groups leads to
recognition of the five main PAD clinical
syndromes

• Obtain history of walking impairment and/or limb
  ischemic symptoms
• Obtain a vascular review of symptoms
• Leg discomfort with exertion
• Leg pain at rest non-healing wound gangrene

No leg pain
Classic claudication
Chronic critical limb ischemia (CLI)
Acute limb ischemia (ALI)
Atypical leg pain
Perform a resting ankle-brachial index measurement
27
How to Perform an ABI Exam

• Performed with the patient resting in the supine
  position
• All pressures are measured with an arterial
  Doppler and appropriately sized blood pressure
  cuff (edge 1-2 inches above the pulse cuff width
  should be 40 of limb circumference).
• Systolic pressures will be measured in the right
  and left brachial arteries followed by the right
  and left ankle arteries.

28
ABI Procedure

• Step 1 Apply the appropriately sized blood
  pressure cuff on the arm above the elbow (either
  arm).
• Step 2 Apply Doppler gel to skin surface.
• Step 3 Turn on the Doppler and place the probe
  in the area of the pulse at a 45-60 angle to the
  surface of the skin, pointing to the shoulder.
• Step 4 Move the probe around until the clearest
  arterial signal is heard.

29
ABI Procedure
http//www.nhlbi.nih.gov/health/dci/Diseases/pad/p
ad_diagnosis.html
30
ABI Procedure

• Step 5 Inflate the blood pressure cuff to
  approximately 20 mmHg above the point where
  systolic sounds are no longer heard.
• Step 6 Gradually deflate until the arterial
  signal returns. Record the pressure reading.
• Step 7 Repeat the procedure for the right and
  left posterior tibial and dorsalis pedis
  arteries. Place the probe on the pulse and angle
  the probe at 45o toward the knee.
• Step 8 Record the systolic blood pressure of the
  contralateral arm.

31
Understanding the ABI

• The ratio of the higher brachial systolic
  pressure and the higher ankle systolic pressure
  for each leg

ABI
32
Calculate the ABI

• For the left side, divide the left ankle pressure
  by the highest brachial pressure and record the
  result.
• Repeat the steps for the right side.
• Record the ABIs and place the results in the
  medical record.

Right Leg ABI
Left Leg ABI
Right Ankle Pressure
Left Ankle Pressure
Highest Arm Pressure
Highest Arm Pressure
ABI Interpretation 0.90 is diagnostic of
peripheral arterial disease
Hiatt WR. N Engl J Med. 20013441608-1621 TASC
Working Group. J Vasc Surg. 200031(1Suppl)S1-S29
6.
33
The Ankle-Brachial Index

• Lower extremity systolic pressure
• Brachial artery systolic pressure

ABI

• The ankle-brachial index is 95 sensitive and 99
  specific for PAD
• Establishes the PAD diagnosis
• Identifies a population at high risk of CV
  ischemic events
• The population at risk can be clinically and
  epidemiologically defined

• Age less than 50 years with diabetes, and one
  additional risk factor Age 50 to 69 years and
  history of smoking or diabetes
• Age 70 years and older
• Leg symptoms with exertion (suggestive of
  claudication) or ischemic rest pain
• Abnormal lower extremity pulse examination
• Known atherosclerotic coronary, carotid, or renal
  artery disease

• Toe-brachial index (TBI) useful in individuals
  with non-compressible pedal pulses

Lijmer JG. Ultrasound Med Biol 199622391-8
Feigelson HS. Am J Epidemiol 1994140526-34
Baker JD. Surgery 198189134-7 Ouriel K. Arch
Surg 19821171297-13 Carter SA. J Vasc Surg
200133708-14
34
Interpreting the Ankle-Brachial Index
Adapted from Hirsch AT, et al. J Am Coll Cardiol.
200647e1-e192. Figure 6.
35
Using the ABI An Example
ABIankle-brachial index DPdorsalis pedis
PTposterior tibial SBPsystolic blood pressure.
36
ABI Limitations

• Incompressible arteries (elderly patients,
  patients with diabetes, renal failure, etc.)
• Resting ABI may be insensitive for detecting mild
  aorto-iliac occlusive disease
• Not designed to define degree of functional
  limitation
• Normal resting values in symptomatic patients may
  become abnormal after exercise
• Note Non-compressible pedal arteries is a
  physiologic term and such arteries need not be
  calcified

37
Toe-Brachial Index Measurement

• The toe-brachial index (TBI) is calculated by
  dividing the toe pressure by the higher of the
  two brachial pressures.
• TBI values remain accurate when ABI values are
  not possible due to non-compressible pedal
  pulses.
• TBI values 0.7 are usually considered
  diagnostic for lower extremity PAD.

38
Hemodynamic Noninvasive Tests

• Resting Ankle-Brachial Index (ABI)
• Exercise ABI
• Segmental pressure examination
• Pulse volume recordings

These traditional tests continue to provide a
simple, risk-free, and cost-effective approach
to establishing the PAD diagnosis as well as to
follow PAD status after procedures.
39
Segmental Pressures (mm Hg)
150
150
Brachial
150
150
110
146
108
100
62
84
0.54
0.44
ABI
40
Pulse Volume Recordings
41
Exercise ABI Testing

• Confirms the PAD diagnosis
• Assesses the functional severity of claudication
• May unmask PAD when resting the ABI is normal
• Aids differentiation of intermittent claudication
  vs. pseudoclaudication diagnoses

42
Exercise ABI Testing Treadmill

• Indicated when the ABI is normal or borderline
  but symptoms are consistent with claudication
• An ABI fall post-exercise supports a PAD
  diagnosis
• Assesses functional capacity (patient symptoms
  may be discordant with objective exercise
  capacity).

.
43
The Plantar Flexion Exercise ABI

• Benefits
• Reproduces treadmill-derived fall in ABI
• Can be performed anywhere
• Inexpensive
• Limitation
• Does not measure functional capacity

Reprinted with permission from McPhail, IR et al.
J Am Coll Cardiol. 2001371381.
44
Color Duplex Ultrasonography
45
Arterial Duplex Ultrasound Testing

• Duplex ultrasound of the extremities is useful to
  diagnose anatomic location and degree of stenosis
  of peripheral arterial disease.
• Duplex ultrasound is useful to provide
  surveillance following femoral-popliteal bypass
  using venous conduit (but not prosthetic grafts).
  
• Duplex ultrasound of the extremities can be used
  to select candidates for
• endovascular intervention
• surgical bypass, and
• to select the sites of surgical anastomosis.

However, the data that might support use of
duplex ultrasound to assess long-term patency of
PTA is not robust.
PTApercutaneous transluminal angioplasty.
46
Noninvasive Imaging Tests
Duplex Ultrasound
Duplex ultrasound of the extremities is useful to
diagnose the anatomic location and degree of
stenosis of PAD. Duplex ultrasound is
recommended for routine surveillance after
femoral-popliteal or femoral- tibial-pedal bypass
with a venous conduit. Minimum surveillance
intervals are approximately 3, 6, and 12 months,
and then yearly after graft placement.
47
Magnetic Resonance Angiography (MRA)

• MRA has virtually replaced contrast arteriography
  for PAD diagnosis
• Excellent arterial picture
• No ionizing radiation
• Noniodinebased intravenous contrast medium
  rarely causes renal insufficiency or allergic
  reaction
• 10 of patients cannot utilize MRA because of
• Claustrophobia
• Pacemaker/implantable cardioverter-defibrillator
• Obesity
• Gadolinium use in individuals with an eGFR lt60
  mL/min has been associated with nephrogenic
  systemic fibrosis (NSF)/nephrogenic fibrosing
  dermopathy

48
Noninvasive Imaging Tests
Magnetic Resonance Angiography (MRA)
MRA of the extremities is useful to
diagnose anatomic location and degree of stenosis
of PAD. MRA of the extremities should be
performed with gadolinium enhancement. MRA of
the extremities is useful in selecting patients
with lower extremity PAD as candidates for
endovascular intervention.
49
Computed Tomographic Angiography (CTA)

• Requires iodinated contrast
• Requires ionizing radiation
• Produces an excellent arterial picture

50
Computed Tomographic Angiography (CTA)

• Requires iodinated contrast
• Requires ionizing radiation
• Produces an excellent arterial picture

51
Noninvasive Imaging Tests
Computed Tomographic Angiography (CTA)

• CTA of the extremities may be considered
• to diagnose anatomic location and
• presence of significant stenosis in
• patients with lower extremity PAD.
• CTA of the extremities may be considered
• as a substitute for MRA for those patients
• with contraindications to MRA.

52
The PAD Guideline ProvidesSteps Toward Ideal PAD
Care
Take strides to improve the standard of PAD care
53
ACC/AHA Guideline for the Management of
PADSteps Toward the Diagnosis of PAD
Individuals at risk for PAD
Age 50 to 69 years and history of smoking or
diabetes Age 70 years Abnormal lower extremity
pulse examination Known atherosclerotic coronary,
carotid, or renal arterial disease

• Obtain history of walking impairment and/or limb
  ischemic symptoms Obtain a vascular review of
  symptoms
• Leg discomfort with exertion
• Leg pain at rest nonhealing wound gangrene

Acute limb ischemia (ALI)
Chronic critical limb ischemia (CLI)
No leg pain
Classic claudication
Atypical leg pain
Perform a resting ankle-brachial index measurement
Diagnosis and Treatment of Acute Limb Ischemia
Diagnosis and Treatment of Asymptomatic PAD and
Atypical Leg Pain
Diagnosis and Treatment of Asymptomatic PAD and
Atypical Leg Pain
Diagnosis and Treatment of Claudication
Diagnosis and Treatment of Critical Limb Ischemia
Hirsch AT, et al. J Am Coll Cardiol.
200647e1-e192.
54
ACC/AHA Guideline for the Management of
PADDiagnosis and Treatment of Asymptomatic PAD
Individual at PAD risk No leg symptoms or
atypical leg symptoms Consider use of the San
Diego Walking Impairment Questionnaire
Perform a resting ankle-brachial index measurement
ABI 0.91 to 1.30 (borderline normal)
ABI 1.30 (abnormal)
ABI 0.90 (abnormal)
Pulse volume recording Toe-brachial
index (Duplex ultrasonography)
Measure ABI after exercise test
Normal results No PAD
Abnormal results
Normal post-exercise ABI No PAD
Decreased post-exercise ABI
Confirmation of PAD diagnosis
Evaluate other causes of leg symptoms
Hirsch AT, et al. J Am Coll Cardiol.
200647e1-e192.
55
ACC/AHA Guideline for the Management of
PADDiagnosis and Treatment of Asymptomatic PAD
Confirmation of PAD diagnosis
Risk factor normalization Immediate smoking
cessation Treat hypertension JNC-7
guidelines Treat lipids NCEP ATP III
guidelines Treat diabetes mellitus HbA1c less
than 7
Pharmacological Risk Reduction Antiplatelet
therapy (ACE inhibition Class IIb, LOE C)
ACEangiotensin-converting enzyme JNC-7Joint
National Committee on Prevention NCEPNational
Cholesterol Education Program Adult Treatment
Panel III.
Hirsch AT, et al. J Am Coll Cardiol.
200647e1-e192.
56
ACC/AHA Guideline for the Management of
PADDiagnosis of Claudication and Systemic Risk
Treatment
Classic Claudication Symptoms Muscle fatigue,
cramping, or pain that reproducibly begins during
exercise and that promptly resolves with rest
Chart document the history of walking impairment
(pain-free and total walking distance) and
specific lifestyle limitations
Document pulse examination
Exercise ABI (TBI, segmental pressure, or Duplex
ultrasound examination)
ABI greater than 0.90
ABI
Normal results
Abnormal results
ABI less than or equal to 0.90
Confirmed PAD diagnosis
No PAD or consider arterial entrapment syndromes
Contd
Hirsch AT, et al. J Am Coll Cardiol.
200647e1-e192.
ABIankle-brachial index TBItoe-brachial index.
57
ACC/AHA Guideline for the Management of PAD
Diagnosis of Claudication and Systemic Risk
Treatment
Confirmed PAD diagnosis
Risk factor normalization Immediate smoking
cessation Treat hypertension JNC-7
guidelines Treat lipids NCEP ATP III
guidelines Treat diabetes mellitus HbA1c less
than 7
Pharmacological risk reduction Antiplatelet
therapy (ACE inhibition Class IIa)
Treatment of Claudication
ACEangiotensin-converting enzyme JNC-7Joint
National Committee on Prevention NCEPNational
Cholesterol Education Program Adult Treatment
Panel III.
Hirsch AT, et al. J Am Coll Cardiol.
200647e1-e192.
58
ACC/AHA Guideline for the Management of
PADTreatment of Claudication
Confirmed PAD Diagnosis
Lifestyle-limiting symptoms
Lifestyle-limiting symptoms with evidence of
inflow disease
No significant functional disability
Pharmacological therapy Cilostazol (Pentoxifyllin
e)
Supervised exercise program

• No claudication treatment required.
• Follow-up visits at least annually to monitor for
  development of leg, coronary, or cerebrovascular
  ischemic symptoms.

Further anatomic definition by more extensive
noninvasive or angiographic diagnostic techniques
Three-month trial
Three-month trial
Endovascular therapy or surgical bypass per
anatomy
Preprogram and postprogram exercise testing for
efficacy
Significant disability despite medical therapy
and/or inflow endovascular therapy, with
documentation of outflow PAD, with favorable
procedural anatomy and procedural risk-benefit
ratio
Clinical improvement Follow-up visits at least
annually
Evaluation for additional endovascular or
surgical revascularization
Hirsch AT, et al. J Am Coll Cardiol.
200647e1-e192.
59
ACC/AHA Guideline for the Management of
PADDiagnosis and Treatment of Critical Limb
Ischemia
Chronic CLI symptoms Ischemic rest pain,
gangrene, nonhealing wound Ischemic etiology must
be established promptly by examination and
objective vascular studies Implication Impending
limb loss
History and physical examination Document lower
extremity pulses Document presence of ulcers or
infection
Assess factors that may contribute to limb
risk diabetes, neuropathy, chronic renal
failure, infection
No or minimal atherosclerotic arterial occlusive
disease
ABI, TBI, or Duplex US
Evaluation of source (ECG or Holter monitor TEE
and/or abdominal US, MRA, or CTA) or venous
Duplex
Severe lower extremity PAD documented ABI less
than 0.4 flat PVR waveform absent pedal flow
Consider atheroembolism, thromboembolism, or
phlegmasia cerulea dolens
Contd
ABIankle-brachial index CLIcritical limb
ischemia CTAcomputed tomographic angiography
ECGelectrocardiogram MRAmagnetic resonance
angiography PVRpulse volume recording
TEEtransesophageal echocardiogram
TBItoe-brachial index US ultrasound.
Hirsch AT, et al. J Am Coll Cardiol.
200647e1-e192.
60
ACC/AHA Guideline for the Management of
PADDiagnosis and Treatment of Critical Limb
Ischemia (1)
Severe lower extremity PAD documented ABI less
than 0.4 flat PVR waveform absent pedal flow
Systemic antibiotics if skin ulceration and limb
infection are present

• Obtain prompt vascular specialist consultation
• Diagnostic testing strategy
• Creation of therapeutic intervention plan

Patient is not a candidate for revascularization
Patient is a candidate for revascularization
Medical therapy or amputation (when necessary)
Contd
Ongoing vascular surveillance
Written instructions for self-surveillance
ABIankle-brachial index PVRpulse volume
recording. Hirsch AT, et al. J Am Coll Cardiol.
200647e1-e192.
61
ACC/AHA Guideline for the Management of
PADDiagnosis and Treatment of Critical Limb
Ischemia (2)
Patient is a candidate for revascularization

• Define limb arterial anatomy
• Assess clinical and objective severity of
  ischemia

Imaging of relevant arterial circulation
(noninvasive and angiographic)
Revascularization possible (see treatment text,
with application of thrombolytic, endovascular,
and surgical therapies)
Revascularization not possible medical
therapy amputation (when necessary)
Ongoing vascular surveillance
Written instructions for self-surveillance
Hirsch AT, et al. J Am Coll Cardiol.
200647e1-e192.